The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study
Open Access
- 22 March 2022
- journal article
- research article
- Published by Springer Nature in Advances in Therapy
- Vol. 39 (5) , 2208-2221
Abstract
Introduction The prevalence of type 2 diabetes (T2D) represents a rising burden in the US and worldwide, with the condition shown to be associated with relatively large human and economic costs. Part of the reason for such high costs associated with T2D is that the condition is often accompanied by additional health-related complications. The goal of this research is to examine the association between glycemic control and diabetes-related complications for individuals with T2D. Methods The Optum Clinformatics® Data Mart (CDM) database from 2007 to 2020 was used to identify adults with T2D. Individuals were classified as having sustained glycemic control (all hemoglobin A1c [HbA1c] < 7%) or poor glycemic control (all HbA1c ≥ 7%) over the 5-year post-period, and diabetes-related complications were identified based upon the Diabetes Complications Severity Index. Multivariable analyses examined the association between sustained glycemic control and diagnosis of a diabetes-related complication in the post-period. Results Maintaining HbA1c < 7% over the 5-year post-period, compared to maintaining HbA1c ≥ 7%, was associated with reduced odds of the diabetes-related complications of cardiovascular disease (odds ratio [OR] = 0.76, 95% confidence interval [CI] 0.61–0.94), metabolic disease (OR = 0.37, 95% CI 0.22–0.600), neuropathy (OR = 0.62, 95% CI 0.45–0.84), nephropathy (OR = 0.81, 95% CI 0.69–0.94), and peripheral vascular disease (OR = 0.52, 95% CI 0.33–0.83). There was no statistically significant association between sustained glycemic control and cerebrovascular disease. Conclusions Sustained glycemic control was found to be associated with significant reductions in the odds of being diagnosed with diabetes-related complications over a 5-year post-period.Keywords
Funding Information
- Eli Lilly and Company
This publication has 40 references indexed in Scilit:
- Hyperglycemic Crises in Adult Patients With DiabetesDiabetes Care, 2009
- Elevated Glycosylated Hemoglobin is Associated With Subclinical Neuropathy in Neurologically Asymptomatic Diabetic Patients: A Prospective StudyJournal Of Clinical Neurophysiology, 2009
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesNew England Journal of Medicine, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Relation of the Number of Metabolic Syndrome Risk Factors With All-Cause and Cardiovascular MortalityThe American Journal of Cardiology, 2008
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- The association between metabolic control and prevalent macrovascular disease in Type 2 diabetes: The VA Cooperative Study in diabetesJournal of Diabetes and its Complications, 2006
- Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 DiabetesDiabetes Care, 2005
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998